Nu-Med (NUMD) 0.5100 $NUMD
Nu-Med Plus Contacted by Global Medical Healthcare Provider
Marketwired - Wed Sep 09, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has been contacted by a major producer of gases for Industry, Health and the Environment to discuss Nu-Med Plus's approach to Inhaled Nitric Oxide(NO) delivery.
Nu-Med Plus Announces the Addition of Keith L. Merrell as Their Chief Financial Officer
Marketwired - Tue Aug 04, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced that Keith L. Merrell has accepted the position of Chief Financial Officer replacing Mark Christensen.
Nu-Med Plus Announces New Methodology Using Nitric Oxide for Diabetic Wound Healing
Marketwired - Tue Jul 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced today that it has created the design and methodology by which Nitric Oxide (NO) may well be safely delivered, at optimal levels, to facilitate in the therapeutic healing of chronic diabetic foot ulcers and wounds.
Nu-Med Plus, Inc. Reveals Plan to Develop Clinical Inhaled Nitric Oxide Device Using Inexpensive Technology
Marketwired - Tue Jul 21, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has begun development of an inhaled Nitric Oxide clinical device designed for low cost use in medical office environments.
Nu-Med Plus, Inc. Selects NT Associates as Its Strategic Public Relations Partner
Marketwired - Tue Jul 14, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm NT Associates as its strategic public relations partner. NT Associates will be responsible for directing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.
Nu-Med Plus Draws Global Attention as MERS, SARS and Bird Flu Threats Continue to Increase
Marketwired - Tue Jul 07, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has drawn worldwide attention with the increased threats to national economies coming from the spread of MERS, SARS and the Bird Flu.
Nu-Med Plus Announces Increased Patient Safety of Portable Inhaled Nitric Oxide Delivery
Marketwired - Tue Jun 30, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced that a visual indicator has been created that increases the safe therapeutic delivery of nitric oxide. The indicator is a quick visual check to ensure that by-products of the delivery of nitric oxide are not present in potentially toxic levels.
Nu-Med Plus, Inc. Selects Affinity Advisors, LLC as Their Strategic Public Relations Partner
Marketwired - Tue Jun 16, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm Affinity Advisors as its strategic public relations partner. Affinity Advisors will be responsible for strategizing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.
Nu-Med Plus Develops Proprietary Compressed Tablet for Inhaled Nitric Oxide Delivery System for Hospitals
Marketwired - Tue Jun 02, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a compressed proprietary tablet formulation for ease of handling and efficiency for their Inhaled Nitric Oxide Hospital System for use in Adults, Pediatrics and Neonates who are on a ventilator in a hospital setting under close medical supervision.
Nu-Med Plus Announces Computer Based Analyzer for Their Portable Inhaled Nitric Oxide System
Marketwired - Tue May 19, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a computer based analyzer and calibration software to complement their Portable/Rechargeable Inhaled Nitric Oxide unit. The completion of the analyzer is another step in providing a total solution for the administration of nitric oxide in a non-hospital setting. It is designed to be intuitive and simple to use.
Nu-Med Plus, Inc. Applies for Patent on Portable/Rechargeable Inhaled Nitric Oxide Delivery System
Marketwired - Tue May 05, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its Portable Inhaled Nitric Oxide delivery technology.
Nu-Med Plus Announces the Addition of Charles Ivester M.D., Ph.D., to Their Medical Advisory Board
Marketwired - Tue Apr 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Charles Ivester M.D., Ph.D. to their Medical Advisory Board.
Nu-Med Plus elects Mark Christensen as CFO
M2 - Tue Apr 21, 8:42AM CDT
Medical device company Nu-Med Plus (OTCBB:NUMD) disclosed on Tuesday the addition of Mark Christensen MPrA, CPA as its chief financial officer.
Nu-Med Plus Announces the Addition of Mark Christensen M.Pr.A., C.P.A. as Chief Financial Officer
Marketwired - Tue Apr 21, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Mark Christensen as their Chief financial Officer.
Nu-Med Plus Selects Tom Tait as VP of Scientific Advancement and to Their Board of Directors
Marketwired - Tue Apr 14, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the appointment of Tom Tait to their Board of Directors and correspondingly an Officer of the Company.
Nu-Med Plus Announces the Selection of Brett J. Earl M.D as VP of Medical Marketing and to Their Board of Directors
Marketwired - Tue Apr 07, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the appointment of Brett J. Earl M.D. to their Board of Directors and also an Officer of the Company.
Nu-Med Plus Introduces Portable/Rechargeable Nitric Oxide Delivery System
Marketwired - Tue Mar 31, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a lightweight Portable/Rechargeable Nitric Oxide Delivery System.
Nu-Med Plus Inc. Files Patent for Low Cost Nitric Oxide Technology
Marketwired - Tue Mar 24, 9:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its low cost Nitric Oxide delivery technology.
Nu-Med Plus Develops Low Cost Nitric Oxide Delivery System for Hospitals
Marketwired - Tue Mar 17, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a hospital unit to deliver and monitor Inhaled Nitric Oxide for use in Adults, Pediatrics and Neonates who are on a ventilator in a hospital setting under close medical supervision. It is designed to be modest and instinctive to use.
Nu-Med Plus Contacted by Global Medical Healthcare Provider
Marketwired - Wed Sep 09, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has been contacted by a major producer of gases for Industry, Health and the Environment to discuss Nu-Med Plus's approach to Inhaled Nitric Oxide(NO) delivery.
Nu-Med Plus Announces the Addition of Keith L. Merrell as Their Chief Financial Officer
Marketwired - Tue Aug 04, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced that Keith L. Merrell has accepted the position of Chief Financial Officer replacing Mark Christensen.
Nu-Med Plus Announces New Methodology Using Nitric Oxide for Diabetic Wound Healing
Marketwired - Tue Jul 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced today that it has created the design and methodology by which Nitric Oxide (NO) may well be safely delivered, at optimal levels, to facilitate in the therapeutic healing of chronic diabetic foot ulcers and wounds.
Nu-Med Plus, Inc. Reveals Plan to Develop Clinical Inhaled Nitric Oxide Device Using Inexpensive Technology
Marketwired - Tue Jul 21, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has begun development of an inhaled Nitric Oxide clinical device designed for low cost use in medical office environments.
Nu-Med Plus, Inc. Selects NT Associates as Its Strategic Public Relations Partner
Marketwired - Tue Jul 14, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm NT Associates as its strategic public relations partner. NT Associates will be responsible for directing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.
Nu-Med Plus Draws Global Attention as MERS, SARS and Bird Flu Threats Continue to Increase
Marketwired - Tue Jul 07, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has drawn worldwide attention with the increased threats to national economies coming from the spread of MERS, SARS and the Bird Flu.
Nu-Med Plus Announces Increased Patient Safety of Portable Inhaled Nitric Oxide Delivery
Marketwired - Tue Jun 30, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced that a visual indicator has been created that increases the safe therapeutic delivery of nitric oxide. The indicator is a quick visual check to ensure that by-products of the delivery of nitric oxide are not present in potentially toxic levels.
Nu-Med Plus, Inc. Selects Affinity Advisors, LLC as Their Strategic Public Relations Partner
Marketwired - Tue Jun 16, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm Affinity Advisors as its strategic public relations partner. Affinity Advisors will be responsible for strategizing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.
Nu-Med Plus Develops Proprietary Compressed Tablet for Inhaled Nitric Oxide Delivery System for Hospitals
Marketwired - Tue Jun 02, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a compressed proprietary tablet formulation for ease of handling and efficiency for their Inhaled Nitric Oxide Hospital System for use in Adults, Pediatrics and Neonates who are on a ventilator in a hospital setting under close medical supervision.
Nu-Med Plus Announces Computer Based Analyzer for Their Portable Inhaled Nitric Oxide System
Marketwired - Tue May 19, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a computer based analyzer and calibration software to complement their Portable/Rechargeable Inhaled Nitric Oxide unit. The completion of the analyzer is another step in providing a total solution for the administration of nitric oxide in a non-hospital setting. It is designed to be intuitive and simple to use.
Nu-Med Plus, Inc. Applies for Patent on Portable/Rechargeable Inhaled Nitric Oxide Delivery System
Marketwired - Tue May 05, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its Portable Inhaled Nitric Oxide delivery technology.
Nu-Med Plus Announces the Addition of Charles Ivester M.D., Ph.D., to Their Medical Advisory Board
Marketwired - Tue Apr 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Charles Ivester M.D., Ph.D. to their Medical Advisory Board.
Nu-Med Plus elects Mark Christensen as CFO
M2 - Tue Apr 21, 8:42AM CDT
Medical device company Nu-Med Plus (OTCBB:NUMD) disclosed on Tuesday the addition of Mark Christensen MPrA, CPA as its chief financial officer.
Nu-Med Plus Announces the Addition of Mark Christensen M.Pr.A., C.P.A. as Chief Financial Officer
Marketwired - Tue Apr 21, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Mark Christensen as their Chief financial Officer.
Nu-Med Plus Selects Tom Tait as VP of Scientific Advancement and to Their Board of Directors
Marketwired - Tue Apr 14, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the appointment of Tom Tait to their Board of Directors and correspondingly an Officer of the Company.
Nu-Med Plus Announces the Selection of Brett J. Earl M.D as VP of Medical Marketing and to Their Board of Directors
Marketwired - Tue Apr 07, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the appointment of Brett J. Earl M.D. to their Board of Directors and also an Officer of the Company.
Nu-Med Plus Introduces Portable/Rechargeable Nitric Oxide Delivery System
Marketwired - Tue Mar 31, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a lightweight Portable/Rechargeable Nitric Oxide Delivery System.
Nu-Med Plus Inc. Files Patent for Low Cost Nitric Oxide Technology
Marketwired - Tue Mar 24, 9:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its low cost Nitric Oxide delivery technology.
Nu-Med Plus Develops Low Cost Nitric Oxide Delivery System for Hospitals
Marketwired - Tue Mar 17, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a hospital unit to deliver and monitor Inhaled Nitric Oxide for use in Adults, Pediatrics and Neonates who are on a ventilator in a hospital setting under close medical supervision. It is designed to be modest and instinctive to use.
